Form 4 holding
Chief Commercial Officer
BIOCRYST PHARMACEUTICALS INC
- Security class
- Common Stock
- Shares / value
- 258,372
- Estimated value
- $2,015,146
- Report date
- 01 Jan 2026
- Price
- $7.80
- Ownership
- Direct
Ronald Dullinger - Chief Commercial Officer at BIOCRYST PHARMACEUTICALS INC
Issuer-level insider activity
- Role
- Chief Commercial Officer
- Issuer ticker
- BCRX on Nasdaq
- Entity type
- Individual
- Source filing history
- Open source filing history
Identity
Names, identifiers, and filing context for this profile.
1 identity field
Source evidence
Original filing metadata and source links for verification.
1 source field
No buys or sells have been reported by Ronald Dullinger since 06 Oct 2025
Reported holdings for Ronald Dullinger in BIOCRYST PHARMACEUTICALS INC
Transaction history for Ronald Dullinger in BIOCRYST PHARMACEUTICALS INC
| Sym | Class | Transaction | % | SEC-reported value | SEC-reported price | Shares | Shares after | Date | Ownership |
|---|
* marks a reported price that did not pass the local price check.